Aza-Peptide Epoxides: Potent and Selective Inhibitors of Schistosoma mansoni and Pig Kidney Legumains (Asparaginyl Endopeptidases)

Verfasser / Beitragende:
[K. E. James, M. G. Götz, C. R. Caffrey, E. Hansell, W. Carter, A. J. Barrett, J. H. McKerrow, J. C. Powers]
Ort, Verlag, Jahr:
2003
Enthalten in:
Biological Chemistry, 384/12(2003-12-25), 1613-1618
Format:
Artikel (online)
ID: 378855972
LEADER caa a22 4500
001 378855972
003 CHVBK
005 20180305123335.0
007 cr unu---uuuuu
008 161128e20031225xx s 000 0 eng
024 7 0 |a 10.1515/BC.2003.179  |2 doi 
035 |a (NATIONALLICENCE)gruyter-10.1515/BC.2003.179 
245 0 0 |a Aza-Peptide Epoxides: Potent and Selective Inhibitors of Schistosoma mansoni and Pig Kidney Legumains (Asparaginyl Endopeptidases)  |h [Elektronische Daten]  |c [K. E. James, M. G. Götz, C. R. Caffrey, E. Hansell, W. Carter, A. J. Barrett, J. H. McKerrow, J. C. Powers] 
520 3 |a Aza-peptide epoxides are a new class of irreversible cysteine protease inhibitors. Derivatives containing a P1 aza-asparagine residue are specific for Schistosoma mansoni and pig kidney legumains, which are clan CD cysteine proteases. The inhibitors have secondorder rate constants of up to 104 M-1s -1 with pig kidney legumain and IC50 values as low as 45 nM with S. mansoni legumain. The most potent epoxides contain an ester moiety with S,S stereochemistry attached to the epoxide. Interestingly, amide and amino acid derivatives of the epoxysuccinate moiety were not inhibitors of legumain, while disubstituted amide derivatives are quite potent. The inhibitors have little or no inhibitory activity with other proteases such as caspases, chymotrypsin, papain, cathepsin B, granzyme B, and various aspartyl proteases. 
540 |a Copyright © 2003 by Walter de Gruyter GmbH & Co. KG 
690 7 |a Biochemistry  |2 nationallicence 
690 7 |a Molecular biology  |2 nationallicence 
690 7 |a Cellular biology  |2 nationallicence 
700 1 |a James  |D K. E.  |4 aut 
700 1 |a Götz  |D M. G.  |4 aut 
700 1 |a Caffrey  |D C. R.  |4 aut 
700 1 |a Hansell  |D E.  |4 aut 
700 1 |a Carter  |D W.  |4 aut 
700 1 |a Barrett  |D A. J.  |4 aut 
700 1 |a McKerrow  |D J. H.  |4 aut 
700 1 |a Powers  |D J. C.  |4 aut 
773 0 |t Biological Chemistry  |d Walter de Gruyter  |g 384/12(2003-12-25), 1613-1618  |x 1431-6730  |q 384:12<1613  |1 2003  |2 384  |o bchm 
856 4 0 |u https://doi.org/10.1515/BC.2003.179  |q text/html  |z Onlinezugriff via DOI 
908 |D 1  |a research article  |2 jats 
950 |B NATIONALLICENCE  |P 856  |E 40  |u https://doi.org/10.1515/BC.2003.179  |q text/html  |z Onlinezugriff via DOI 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a James  |D K. E.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Götz  |D M. G.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Caffrey  |D C. R.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Hansell  |D E.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Carter  |D W.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Barrett  |D A. J.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a McKerrow  |D J. H.  |4 aut 
950 |B NATIONALLICENCE  |P 700  |E 1-  |a Powers  |D J. C.  |4 aut 
950 |B NATIONALLICENCE  |P 773  |E 0-  |t Biological Chemistry  |d Walter de Gruyter  |g 384/12(2003-12-25), 1613-1618  |x 1431-6730  |q 384:12<1613  |1 2003  |2 384  |o bchm 
900 7 |b CC0  |u http://creativecommons.org/publicdomain/zero/1.0  |2 nationallicence 
898 |a BK010053  |b XK010053  |c XK010000 
949 |B NATIONALLICENCE  |F NATIONALLICENCE  |b NL-gruyter